Molecular typing of clinical isolates of Cryptococcus neoformans/Cryptococcus gattii species complex from Northeast Mexico

. 2016 Jan ; 61 (1) : 51-6. [epub] 20150625

Jazyk angličtina Země Spojené státy americké Médium print-electronic

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid26109075
Odkazy

PubMed 26109075
DOI 10.1007/s12223-015-0409-8
PII: 10.1007/s12223-015-0409-8
Knihovny.cz E-zdroje

Cryptococcosis is caused by members of the Cryptococcus neoformans/Cryptococcus gattii species complex. Based on molecular identification, these two species have been further differentiated into molecular types. The aim of this work was to characterize clinical cryptococcal isolates recovered from six hospitals in Northeast Mexico from 1995 to 2011. One hundred and sixty-six isolates, which were characterized by biochemical tests and in vitro susceptibility to amphotericin B, fluconazole, and voriconazole, and M13 PCR fingerprinting, were included in this study. Utilizing phenotypic tests, 153 isolates (92.16 %) were identified as C. neoformans and 13 (7.83 %) as C. gattii. All isolates were susceptible to all antifungals tested. Employing M13 PCR fingerprinting, eight molecular types were detected. VNI was the most common genotype (124 cases; 74.6 %), followed by VNII (15 cases; 9 %), VNIII (8 cases; 4.8 %), VNIV (6 cases; 3.6 %), VGI (6 cases; 3.6 %), VGII (3 cases; 1.8 %), and VGIII and VGIV (2 cases, 1.2 % each). We confirm the presence of C. gattii in clinical isolates in Northeast Mexico, and a high clonal diversity in the studied strains of C. neoformans/C. gattii species complex.

Zobrazit více v PubMed

J Clin Microbiol. 1994 May;32(5):1188-92 PubMed

Curr Genet. 1997 Sep;32(3):203-8 PubMed

J Clin Microbiol. 1997 Sep;35(9):2243-51 PubMed

Med Mycol. 2009 Nov;47(7):713-21 PubMed

Can Vet J. 2002 Oct;43(10):792-4 PubMed

Med Mycol. 2012 Apr;50(3):328-32 PubMed

Mycoses. 1991 Sep-Oct;34(9-10):377-9 PubMed

Nature. 2005 Oct 27;437(7063):1360-4 PubMed

Antimicrob Agents Chemother. 2010 Dec;54(12):5139-45 PubMed

Antimicrob Agents Chemother. 2001 Nov;45(11):3065-9 PubMed

Springerplus. 2013 Nov 23;2:632 PubMed

J Clin Microbiol. 2010 Nov;48(11):4115-20 PubMed

Eur J Clin Microbiol Infect Dis. 2004 Jun;23(6):506-8 PubMed

Emerg Infect Dis. 2003 Feb;9(2):189-95 PubMed

Mycopathologia. 2013 Oct;176(3-4):267-72 PubMed

Med Mycol. 2004 Jun;42(3):229-38 PubMed

Infect Immun. 1989 Sep;57(9):2624-7 PubMed

Infect Dis Clin North Am. 2006 Sep;20(3):507-44, v-vi PubMed

Emerg Infect Dis. 2007 Jan;13(1):51-7 PubMed

J Antimicrob Chemother. 2005 Dec;56(6):1144-7 PubMed

Mycoses. 2002 Nov;45(9-10):378-83 PubMed

Clin Microbiol Rev. 1995 Oct;8(4):515-48 PubMed

Scientifica (Cairo). 2013;2013:675213 PubMed

Rev Iberoam Micol. 2008 Mar;25(1):S4-12 PubMed

PLoS One. 2013 Aug 07;8(8):e71148 PubMed

BMC Infect Dis. 2010 Oct 04;10:289 PubMed

Clin Infect Dis. 2010 Feb 1;50(3):338-44 PubMed

J Clin Microbiol. 2012 Jun;50(6):1918-26 PubMed

PLoS One. 2013 Apr 17;8(4):e61921 PubMed

Mycoses. 2012 May;55(3):e145-50 PubMed

Clin Microbiol Infect. 2008 Jul;14(7):727-30 PubMed

Mycopathologia. 2010 Oct;170(4):279-85 PubMed

Rev Iberoam Micol. 1999 Mar;16(1):40-2 PubMed

Am J Epidemiol. 1977 Jun;105(6):582-6 PubMed

J Clin Microbiol. 2005 May;43(5):2163-7 PubMed

J Antimicrob Chemother. 2003 Oct;52(4):683-6 PubMed

J Clin Microbiol. 2010 Feb;48(2):539-44 PubMed

Clin Microbiol Infect. 2013 Aug;19(8):763-9 PubMed

Lancet Infect Dis. 2005 Sep;5(9):530-1 PubMed

J Clin Microbiol. 1999 Mar;37(3):715-20 PubMed

Med Mycol. 2008 Nov;46(7):685-96 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...